Clinical Trials Management, LLC | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Active, not recruiting	Phase 2	2026-10-07		NCT06598943
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa	Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder	Active, not recruiting	Phase 2 / Phase 3	2026-10-01		NCT07287644
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Active, not recruiting	Phase 2	2026-07-30		NCT07105488
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense	Acneiform Eruptions, Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, acne, bacterial infectious disease, dermatitis, hidradenitis, hidradenitis suppurativa, sebaceous gland disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder	Active, not recruiting	Phase 2	2026-06-30		NCT06993610
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis	Acute Gastroenteritis; Norovirus Acute Gastroenteritis	Active, not recruiting	Phase 3	2026-05-13		NCT06592794